Case Study

Using De-Identified Linked Real-World Data To Create An External Control Arm In Non-Small Cell Lung Cancer

Source: Datavant

A pharmaceutical company designed its Phase II study of a novel agent to treat metastatic non-small cell lung cancer driven by a rare subtype of EGFR genetic mutation. This type of lung cancer only affected a small subset of EGFR patients, therefore designing studies and finding patients for clinical trials was difficult. The client decided that constructing a control arm out of real-world electronic health record data would be the best approach to the trial.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader